Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
14 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-to-present-tissue-targeted-complement-inhibitor-adx-097-positive-phase-1-clinical-trial-results-at-the-american-society-of-nephrology-kidney-week-2024-302274267.html
09 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-announces-completion-of-enrollment-in-the-signal-ad-phase-2-clinical-trial-of-bempikibart-for-atopic-dermatitis-302191198.html
01 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-joins-russell-3000-index-302186365.html
09 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-reports-first-quarter-2024-financial-results-and-provides-corporate-update-302140475.html
25 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-announces-closing-of-merger-with-homology-medicines-and-concurrent-private-placement-of-42-million-302098557.html
21 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/q32-bio-announces-publication-of-preclinical-data-in-molecular-therapy-demonstrating-the-therapeutic-potential-of-tissue-targeted-complement-inhibitor-adx-097-for-complement-mediated-diseases-302066751.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?